From Detection to Prediction: Modern Analytical Approaches for Nitrosamine Risk

Nitrosamines have been known carcinogens for decades, but their emergence in pharmaceutical products in 2018 transformed them into a central regulatory and analytical priority.¹ What began as a targeted investigation into a handful of small nitrosamines has since expanded into a complex, mechanism-driven discipline requiring predictive assessment, structural evaluation, and highly sensitive analytical methods.